|
1
|
Longhi A, Errani C, De Paolis M, Mercuri M
and Bacci G: Primary bone osteosarcoma in the pediatric age: State
of the art. Cancer Treat Rev. 32:423–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Picci P: Osteosarcoma (osteogenic
sarcoma). Orphanet J Rare Dis. 2:62007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meyers PA and Gorlick R: Osteosarcoma.
Pediatr Clin North Am. 44:973–989. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dorfman HD and Czerniak B: Bone cancers.
Cancer. 75 Suppl:203–210. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wittig JC, Bickels J, Priebat D, Jelinek
J, Kellar-Graney K, Shmookler B and Malawer MM: Osteosarcoma: A
multidisciplinary approach to diagnosis and treatment. Am Fam
Physician. 65:1123–1132. 2002.PubMed/NCBI
|
|
6
|
Ferguson WS and Goorin AM: Current
treatment of osteosarcoma. Cancer Invest. 19:292–315. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ta HT, Dass CR, Choong PF and Dunstan DE:
Osteosarcoma treatment: State of the art. Cancer Metastasis Rev.
28:247–263. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marina N, Gebhardt M, Teot L and Gorlick
R: Biology and therapeutic advances for pediatric osteosarcoma.
Oncologist. 9:422–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schwarz R, Bruland O, Cassoni A, Schomberg
P and Bielack S: The role of radiotherapy in oseosarcoma. Cancer
Treat Res. 152:147–164. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Anderson PM, Wiseman GA, Erlandson L,
Rodriguez V, Trotz B, Dubansky SA and Albritton K: Gemcitabine
radiosensitization after high-dose samarium for osteoblastic
osteosarcoma. Clin Cancer Res. 11:6895–6900. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bonner WM, Redon CE, Dickey JS, Nakamura
AJ, Sedelnikova OA, Solier S and Pommier Y: GammaH2AX and cancer.
Nat Rev Cancer. 8:957–967. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bassing CH and Alt FW: H2AX may function
as an anchor to hold broken chromosomal DNA ends in close
proximity. Cell Cycle. 3:149–153. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mei L, Hu Q, Peng J, Ruan J, Zou J, Huang
Q, Liu S and Wang H: Phospho-histone H2AX is a diagnostic and
prognostic marker for epithelial ovarian cancer. Int J Clin Exp
Pathol. 8:5597–5602. 2015.PubMed/NCBI
|
|
14
|
van Attikum H and Gasser SM: Crosstalk
between histone modifications during the DNA damage response.
Trends Cell Biol. 19:207–217. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Penna E, Orso F, Cimino D, Vercellino I,
Grassi E, Quaglino E, Turco E and Taverna D: miR-214 coordinates
melanoma progression by upregulating ALCAM through TFAP2 and
miR-148b downmodulation. Cancer Res. 73:4098–4111. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang ZS, Zhong M, Bian YH, Mu YF, Qin SL,
Yu MH and Qin J: MicroRNA-187 inhibits tumor growth and invasion by
directly targeting CD276 in colorectal cancer. Oncotarget.
7:44266–44276. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu Q, Yang G and Qian Y: Loss of
MicroRNA-489-3p promotes osteosarcoma metastasis by activating
PAX3-MET pathway. Mol Carcinog. 56:1312–1321. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang J, He J, Su F, Ding N, Hu W, Yao B,
Wang W and Zhou G: Repression of ATR pathway by miR-185 enhances
radiation-induced apoptosis and proliferation inhibition. Cell
Death Dis. 4:e6992013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jin YY, Chen QJ, Wei Y, Wang YL, Wang ZW,
Xu K, He Y and Ma HB: Upregulation of microRNA-98 increases
radiosensitivity in esophageal squamous cell carcinoma. J Radiat
Res (Tokyo). 57:468–476. 2016. View Article : Google Scholar
|
|
21
|
Wang X, Li Q, Jin H, Zou H, Xia W, Dai N,
Dai XY, Wang D, Xu CX and Qing Y: miR-424 acts as a tumor
radiosensitizer by targeting aprataxin in cervical cancer.
Oncotarget. 7:77508–77515. 2016.PubMed/NCBI
|
|
22
|
Zhang YH, Wang QQ, Li H, Ye T, Gao F and
Liu YC: miR-124 radiosensitizes human esophageal cancer cell TE-1
by targeting CDK4. Genet Mol Res. 15:2016.
|
|
23
|
Song L, Liu S, Zhang L, Yao H, Gao F, Xu D
and Li Q: MiR-21 modulates radiosensitivity of cervical cancer
through inhibiting autophagy via the PTEN/Akt/HIF-1alpha feedback
loop and the Akt-mTOR signaling pathway. Tumour Biol.
37:12161–12168. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mao A, Zhao Q, Zhou X, Sun C, Si J, Zhou
R, Gan L and Zhang H: MicroRNA-449a enhances radiosensitivity by
downregulation of c-Myc in prostate cancer cells. Sci Rep.
6:273462016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin SM, Xia Q, Zhang YQ, Sun AM, Shi YS,
Zheng L and Chen LH: miR-124 regulates radiosensitivity of
colorectal cancer cells by targeting PRRX1. Nan Fang Yi Ke Da Xue
Xue Bao. 36:1110–1116. 2016.(In Chinese). PubMed/NCBI
|
|
26
|
Chen S, Wang Y, Ni C, Meng G and Sheng X:
HLF/miR-132/TTK axis regulates cell proliferation, metastasis and
radiosensitivity of glioma cells. Biomed Pharmacother. 83:898–904.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qian Z, Zhang L, Chen J, Li Y, Kang K, Qu
J, Wang Z, Zhai Y, Li L and Gou D: MiR-328 targeting PIM-1 inhibits
proliferation and migration of pulmonary arterial smooth muscle
cells in PDGFBB signaling pathway. Oncotarget. 7:54998–55011. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Weng JH, Yu CC, Lee YC, Lin CW, Chang WW
and Kuo YL: miR-494-3p induces cellular senescence and enhances
radiosensitivity in human oral squamous carcinoma cells. Int J Mol
Sci. 17:E10922016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guo P, Lan J, Ge J, Nie Q, Guo L, Qiu Y
and Mao Q: MiR-26a enhances the radiosensitivity of glioblastoma
multiforme cells through targeting of ataxia-telangiectasia
mutated. Exp Cell Res. 320:200–208. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ye C, Sun NX, Ma Y, Zhao Q, Zhang Q, Xu C,
Wang SB, Sun SH, Wang F and Li W: MicroRNA-145 contributes to
enhancing radiosensitivity of cervical cancer cells. FEBS Lett.
589:702–709. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cheng DD, Yu T, Hu T, Yao M, Fan CY and
Yang QC: MiR-542-5p is a negative prognostic factor and promotes
osteosarcoma tumorigenesis by targeting HUWE1. Oncotarget.
6:42761–42772. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shen L, Wang P, Yang J and Li X:
MicroRNA-217 regulates WASF3 expression and suppresses tumor growth
and metastasis in osteosarcoma. PLoS One. 9:e1091382014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hu J, Lv G, Zhou S, Zhou Y, Nie B, Duan H,
Zhang Y and Yuan X: The downregulation of miR-182 is associated
with the growth and invasion of osteosarcoma cells through the
regulation of TIAM1 expression. PLoS One. 10:e01211752015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gao Y, Feng Y, Shen JK, Lin M, Choy E,
Cote GM, Harmon DC, Mankin HJ, Hornicek FJ and Duan Z: CD44 is a
direct target of miR-199a-3p and contributes to aggressive
progression in osteosarcoma. Sci Rep. 5:113652015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Niu G, Li B, Sun L and An C: MicroRNA-153
inhibits osteosarcoma cells proliferation and invasion by targeting
TGF-β2. PLoS One. 10:e01192252015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fernandez-Capetillo O, Lee A, Nussenzweig
M and Nussenzweig A: H2AX: The histone guardian of the genome. DNA
Repair (Amst). 3:959–967. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Stucki M and Jackson SP: gammaH2AX and
MDC1: Anchoring the DNA-damage-response machinery to broken
chromosomes. DNA Repair (Amst). 5:534–543. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pinder JB, Attwood KM and Dellaire G:
Reading, writing, and repair: The role of ubiquitin and the
ubiquitin-like proteins in DNA damage signaling and repair. Front
Genet. 4:452013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liao XH, Zheng L, He HP, Zheng DL, Wei ZQ,
Wang N, Dong J, Ma WJ and Zhang TC: STAT3 regulated ATR via
microRNA-383 to control DNA damage to affect apoptosis in A431
cells. Cell Signal. 27:2285–2295. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ikura M, Furuya K, Matsuda S, Matsuda R,
Shima H, Adachi J, Matsuda T, Shiraki T and Ikura T: Acetylation of
histone H2AX at Lys 5 by the TIP60 histone acetyltransferase
complex is essential for the dynamic binding of NBS1 to damaged
chromatin. Mol Cell Biol. 35:4147–4157. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang Y, Huang JW, Li M, Cavenee WK,
Mitchell PS, Zhou X, Tewari M, Furnari FB and Taniguchi T:
MicroRNA-138 modulates DNA damage response by repressing histone
H2AX expression. Mol Cancer Res. 9:1100–1111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang L, Yuan C, Lv K, Xie S, Fu P, Liu X,
Chen Y, Qin C, Deng W and Hu W: Lin28 mediates radiation resistance
of breast cancer cells via regulation of caspase, H2A.X and Let-7
signaling. PLoS One. 8:e673732013. View Article : Google Scholar : PubMed/NCBI
|
